Chem. J. Chinese Universities ›› 2014, Vol. 35 ›› Issue (11): 2353.doi: 10.7503/cjcu20140223

• Organic Chemistry • Previous Articles     Next Articles

Synthesis and Anti-hepatitis B Virus Activities of Heterocyclic Substituted Matijin-Su Derivatives

LIANG Guangping1,2, HU Zhanxing1, LIU Qingchuan3, HUANG Zhengming3, ZHANG Jianxin1, LIANG Guangyi1,*(), XU Bixue1,*()   

  1. 1. Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences,Guiyang 550002, China
    2. Department of Pharmacy, Guiyang College of Traditional Chinese Medicine, Guiyang 550002, China
    3. Department of Pharmacy, No.302 Hospital of PLA, Beijing 100039, China
  • Received:2014-03-17 Online:2014-11-10 Published:2014-10-15
  • Contact: LIANG Guangyi,XU Bixue E-mail:guangyi_liang@126.com;bixue_xu@126.com
  • Supported by:
    † Supported by the National Natural Science Foundation of China(No.81360472) and the National Significant Scientific Equipment Development Program, China(No.2011YQ12003506)

Abstract:

N-(N-Benzoyl-L-phenylalanyl)-O-acetyl-L-phenylalanol was isolated from Dichondra repens Forst., which was a phenylalanine dipeptide compound with anti-HBV activity, named Matijin-Su(MTS). Its chemical skeleton structure was different from that of the existing drugs for anti-HBV. MTS was used as a lead compound base on the better anti-HBV activity by preliminary research. A series of MTS derivatives was designed and synthesized by a series of reactions, such as the formation of an amide(peptide), hydrolysis, condensation, acylation, alkylation and esterification using L-phenylalanine and its substitution as starting materials. The synthesized derivatives of MTS were characterized by 1H NMR, 13C NMR, ESI MS and elemental analysis. Their anti-hepatitis B virus activities against HepG2 2.2.15 cells line in vitro were tested. From the screening results, compounds 5b(IC50=8.20 μg/L, SI=10.26), 5g(IC50=5.58 μg/L, SI=22.78) and 5i(IC50=5.07 μg/L, SI=16.67) exhibited significant anti-HBV activities, the inhibition ratio were 56.57%, 67.06% and 66.83%, respectively.

Key words: Matijin-Su, Derivative, Heterocyclic, Anti-HBV activity

CLC Number: 

TrendMD: